Marshall Wace, LLP Karyopharm Therapeutics Inc. Transaction History

Marshall Wace, LLP

  • $78.4 Billion
  • Q4 2024

A detailed history of Marshall Wace, LLP transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 2,401,413 shares of KPTI stock, worth $1.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,401,413
Previous 2,082,226 15.33%
Holding current value
$1.44 Million
Previous $1.73 Million 5.56%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$0.6 - $0.99 $191,512 - $315,995
319,187 Added 15.33%
2,401,413 $1.63 Million
Q3 2024

Nov 14, 2024
SELL
$0.7 - $1.06 $349,045 - $528,555
-498,637 Reduced 19.32%
2,082,226 $1.73 Million
Q2 2024

Aug 14, 2024
SELL
$0.87 - $1.58 $12,820 - $23,282
-14,736 Reduced 0.57%
2,580,863 $2.25 Million
Q1 2024

May 15, 2024
BUY
$0.72 - $1.66 $481,548 - $1.11 Million
668,817 Added 34.71%
2,595,599 $3.92 Million
Q4 2023

Feb 14, 2024
SELL
$0.68 - $1.31 $174,364 - $335,908
-256,419 Reduced 11.75%
1,926,782 $1.66 Million
Q3 2023

Nov 14, 2023
SELL
$1.14 - $1.81 $297,307 - $472,040
-260,796 Reduced 10.67%
2,183,201 $2.93 Million
Q2 2023

Aug 14, 2023
BUY
$1.79 - $4.59 $821,772 - $2.11 Million
459,091 Added 23.13%
2,443,997 $4.37 Million
Q1 2023

May 15, 2023
SELL
$2.84 - $3.92 $639,900 - $883,242
-225,317 Reduced 10.19%
1,984,906 $7.72 Million
Q4 2022

Feb 14, 2023
BUY
$2.48 - $5.93 $5.09 Million - $12.2 Million
2,051,086 Added 1288.88%
2,210,223 $7.51 Million
Q3 2022

Nov 14, 2022
BUY
$4.08 - $5.82 $555,438 - $792,317
136,137 Added 591.9%
159,137 $868,000
Q2 2022

Aug 15, 2022
BUY
$4.15 - $8.37 $95,450 - $192,509
23,000 New
23,000 $103,000
Q1 2022

May 16, 2022
SELL
$5.91 - $14.38 $53,225 - $129,506
-9,006 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$5.21 - $8.61 $46,921 - $77,541
9,006 New
9,006 $57,000
Q1 2021

May 17, 2021
SELL
$9.85 - $17.69 $2.14 Million - $3.85 Million
-217,430 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$14.15 - $17.19 $2.81 Million - $3.41 Million
198,585 Added 1053.78%
217,430 $3.37 Million
Q3 2020

Nov 16, 2020
BUY
$14.14 - $19.71 $266,468 - $371,434
18,845 New
18,845 $275,000
Q1 2020

May 15, 2020
SELL
$14.38 - $27.72 $4.24 Million - $8.16 Million
-294,512 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$9.23 - $19.67 $2.72 Million - $5.79 Million
294,512 New
294,512 $5.65 Million

Others Institutions Holding KPTI

# of Institutions
94
Shares Held
59.6M
Call Options Held
547K
Put Options Held
67K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $47.9M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email